Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Illinois Tool Works | ITW | Jan 14, 2025 | 252.97 | +1.31 |
Illumina | ILMN | Jan 14, 2025 | 136.48 | -5.37 |
Im Cannabis | IMCC | Jan 14, 2025 | 2.26 | -2.59 |
IMAC | BACK | Jan 14, 2025 | 1.21 | 0.00 |
IMAX | IMAX | Jan 14, 2025 | 23.03 | +0.96 |
Immatics | IMTX | Jan 14, 2025 | 5.97 | -4.48 |
Immersion | IMMR | Jan 14, 2025 | 8.45 | -3.87 |
Immix Biopharma | IMMX | Jan 14, 2025 | 2.00 | -5.66 |
ImmuCell | ICCC | Jan 14, 2025 | 5.18 | -2.81 |
Immuneering A | IMRX | Jan 14, 2025 | 1.95 | -2.99 |
Immunic | IMUX | Jan 14, 2025 | 1.00 | -6.54 |
ImmunityBio | IBRX | Jan 14, 2025 | 2.32 | -6.45 |
Immunocore ADR | IMCR | Jan 14, 2025 | 28.56 | -4.90 |
Immunome | IMNM | Jan 14, 2025 | 9.38 | -6.57 |
ImmunoPrecise Antibodies | IPA | Jan 14, 2025 | 0.46 | -11.71 |
Immunovant | IMVT | Jan 14, 2025 | 22.88 | +0.57 |
Immutep ADR | IMMP | Jan 14, 2025 | 1.93 | -0.52 |
Imperial Oil | IMO | Jan 14, 2025 | 67.06 | +0.68 |
Imperial Petroleum | IMPP | Jan 14, 2025 | 3.34 | -0.89 |
Imperial Petroleum A Pref | IMPPP | Jan 14, 2025 | 25.00 | 0.00 |
Impinj | PI | Jan 14, 2025 | 149.31 | +2.04 |
Imunon | IMNN | Jan 14, 2025 | 0.89 | -2.47 |
IN8bio | INAB | Jan 14, 2025 | 0.32 | -0.16 |
Inari Medical | NARI | Jan 14, 2025 | 79.30 | -0.05 |
Incannex Healthcare ADR | IXHL | Jan 14, 2025 | 1.77 | -1.67 |
Inception Growth Acquisition | IGTA | Jan 14, 2025 | 11.75 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Jan 14, 2025 | 12.00 | 0.00 |
Income Opportunity Realty Investors | IOR | Jan 14, 2025 | 18.49 | +1.68 |
Incyte | INCY | Jan 14, 2025 | 71.93 | -0.61 |
Indaptus Therapeutics | INDP | Jan 14, 2025 | 0.90 | -5.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.